Gerresheimer Sets up New Production Facility for Insulin Pen Systems in Brazil

... DUSSELDORF Germany January 11 /- ... The Gerresheimer Group has set up a new facility for medical plast... Insulin pens are drug-delivery devices in ball-point pen format wh... Apart from the new production facility in Brazil Gerresheimer alr...

DUSSELDORF, Germany, January 11 /PRNewswire-FirstCall/ --
- Expansion of Cooperation With Diabetes Leader Novo Nordisk
- Important Step in the Worldwide Development of Medical Plastic Systems

The Gerresheimer Group has set up a new facility for medical plastic
systems in Indaiatuba (Brazil). The plant is to commence operations early in
2010. On the basis of a long-term cooperation agreement with Novo Nordisk,
components will be produced with state-of-the-art technology for insulin pen
systems for diabetics.

Insulin pens are drug-delivery devices in ball-point pen format which
allow diabetes patients to inject themselves with the regularly required
insulin dose safely and almost painlessly. Novo Nordisk as the world's
leading insulin producer has contracted Gerresheimer to manufacture
components for its insulin pens. Novo Nordisk has a large insulin plant in
Brazil which will in future be supplied locally by the new technology center
of the Gerresheimer Group. For Gerresheimer this is already the fourth
production plant in South America in addition to two existing plants for
standardized pharma plastic packaging in Brazil and one in Argentina.

Apart from the new production facility in Brazil, Gerresheimer already
has two other production facilities for pen systems in Europe.

"Cooperation with Novo Nordisk in Brazil is of substantial strategic
importance for us. We support the customer in developing new markets and at
the same time expand our technological base in South America," says
Gerresheimer CEO Dr. Axel Herberg.

About Gerresheimer

Gerresheimer employs around 10,000 people in 40 locations in Europe,
America and Asia. In the financial year 2008, worldwide sales totaled
EUR1.06bn. The product portfolio ranges from pharma-ceu-tical vials made of
glass and plastic through to complex drug-delivery systems for the pharma &
healthcare industry. These include sterile syringes, inhalers and other
system-based approaches for safe dosage and application of medications. The
Group enjoys a leading position in markets which are characterized by high
technical and regulatory barriers.

(Date:12/7/2016)... Capital Corp. ("Zenith" or the "Company") announces webcast details for ... Annual and Special Meeting. The Zenith Annual ... December 15, 2016 at Mount Royal ... Royal Gate SW, Calgary, Alberta , commencing ... information circular, containing the matters to be considered at the ...

(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...

(Date:11/17/2016)... announces that it has just released a new white paper authored by Zettar that ... speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a ...